Dr. Laura Pedroza

Investment Manager

Dr. Laura Pedroza is an Investment Manager of our HTGF Life Science Team. Prior to that, she worked as a postdoc and obtained her promotion in protein biochemistry at the University of Duisburg-Essen. In addition to her promotion, she continued her education in business administration. During her studies in medical biology at the Universities of Duisburg-Essen and Albert-Ludwigs University Freiburg, she completed various internships and stays abroad in the USA (Boston) and worked as a research assistant at the Fraunhofer Institute for Solar Energy Systems (ISE).

linkedin

Portfolio

Posts & mentions

Press
29. August 2024

Acceleration of Bioprocess Development: IRUBIS secures Pre-Series A Funding led by BioProcess360 Partners

Munich, DE | August 29, 2024 – Biotech startup IRUBIS, developing a state-of-the-art real-time bioprocess monitoring solution, has successfully closed a pre-series A funding round. The financing round was led by BioProcess360 Partners, with participation from previous investors such as High-Tech Gründerfonds (HTGF), Verve Ventures, Ventura BioMed Investors, RoBet KG as well as new and existing business angels from the industry as Dr. Matthias Arnold and Dr. Christoph Bremus. The funds wil
 
BB_Mosanna
Press
11. April 2023

Mosanna Therapeutics Announces a Seed Extension Financing Round to Complete Preparations to Enter the Clinic with MOS-118 in Metabolic Obstructive Sleep Apnea

Company pursuing a highly differentiated small molecule MOS-118 in Metabolic Obstructive Sleep Apnea. New investors, Supermoon Capital and HTGF, join founding investor Forty51 Ventures to complete the Seed syndicate. Company will use the funds to file an IND in preparation for a proof of mechanism and proof of concept in the clinic. Basel, Switzerland, April 11, 2023 – Mosanna Therapeutics AG, a Swiss Biotech company today announced that Supermoon Capital, a US based ven